Literature DB >> 27499825

Recurrent urinary tract infections in healthy and nonpregnant women.

Matthew Glover1, Cristiano G Moreira1, Vanessa Sperandio1, Philippe Zimmern1.   

Abstract

Recurrent urinary tract infections (RUTI) are prevalent and pose significant clinical challenges. Although the term RUTI has long been vaguely defined, a consensus definition has emerged in recent years. The exact etiology behind RUTI remains under debate, with valid arguments for both ascending reinfections as well as persistent infection inside the bladder. These persistent infections exist in the form of quiescent intracellular reservoirs in the mouse model and may represent a novel concept to explain UTI recurrence in humans. Manageable risk factors such as behavioral patterns alongside nonmanageable risk factors including genetic susceptibility are growing fields of investigation. Acute UTI have been studied through two model bacterial strains: Escherichia coli UTI89 and CFT073. However, the clinical relevance to RUTI of these two strains has not been firmly established. Current treatment strategies for RUTI are limited and remain dominated by antibiotic usage despite variable efficacy. The majority of studies in humans have focused on younger groups of women with little information available about the postmenopausal population despite a heightened risk of RUTI in this age group.

Entities:  

Keywords:  intracellular bacterial communities; postmenopausal women; quiescent intracellular reservoir; recurrent urinary tract infections; reinfection; risk factors for urinary tract infections

Year:  2014        PMID: 27499825      PMCID: PMC4973860          DOI: 10.1016/j.urols.2013.11.007

Source DB:  PubMed          Journal:  Urol Sci        ISSN: 1879-5226


  87 in total

1.  Effectiveness and safety of patient initiated single-dose versus continuous low-dose antibiotic prophylaxis for recurrent urinary tract infections in postmenopausal women: a randomized controlled study.

Authors:  Y H Zhong; Y Fang; J Z Zhou; Y Tang; S M Gong; X Q Ding
Journal:  J Int Med Res       Date:  2011       Impact factor: 1.671

Review 2.  Prevention of urinary tract infection.

Authors:  A Stapleton; W E Stamm
Journal:  Infect Dis Clin North Am       Date:  1997-09       Impact factor: 5.982

Review 3.  Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections.

Authors:  C E Nord; L Kager; A Heimdahl
Journal:  Am J Med       Date:  1984-05-15       Impact factor: 4.965

Review 4.  Host subversion by formation of intracellular bacterial communities in the urinary tract.

Authors:  Gregory G Anderson; Steven M Martin; Scott J Hultgren
Journal:  Microbes Infect       Date:  2004-10       Impact factor: 2.700

5.  Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women.

Authors:  J Sheinfeld; A J Schaeffer; C Cordon-Cardo; A Rogatko; W R Fair
Journal:  N Engl J Med       Date:  1989-03-23       Impact factor: 91.245

Review 6.  Epidemiology of urinary tract infections: incidence, morbidity, and economic costs.

Authors:  Betsy Foxman
Journal:  Am J Med       Date:  2002-07-08       Impact factor: 4.965

7.  Recurring urinary tract infection: incidence and risk factors.

Authors:  B Foxman
Journal:  Am J Public Health       Date:  1990-03       Impact factor: 9.308

8.  Biochemical fingerprinting of urinary Escherichia coli causing recurrent infections in women with pyelonephritic renal scarring.

Authors:  S H Jacobson; I Kühn; A Brauner
Journal:  Scand J Urol Nephrol       Date:  1992

9.  ABO blood group, secretor state, and susceptibility to recurrent urinary tract infection in women.

Authors:  D F Kinane; C C Blackwell; R P Brettle; D M Weir; F P Winstanley; R A Elton
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-03

Review 10.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

View more
  21 in total

Review 1.  Rapid Growth and Metabolism of Uropathogenic Escherichia coli in Relation to Urine Composition.

Authors:  Larry Reitzer; Philippe Zimmern
Journal:  Clin Microbiol Rev       Date:  2019-10-16       Impact factor: 26.132

Review 2.  Direct Detection of Tissue-Resident Bacteria and Chronic Inflammation in the Bladder Wall of Postmenopausal Women with Recurrent Urinary Tract Infection.

Authors:  Nicole J De Nisco; Michael Neugent; Jason Mull; Luming Chen; Amy Kuprasertkul; Marcela de Souza Santos; Kelli L Palmer; Philippe Zimmern; Kim Orth
Journal:  J Mol Biol       Date:  2019-04-17       Impact factor: 5.469

3.  Persistent Escherichia coli infection in renal tubular cells enhances calcium oxalate crystal-cell adhesion by inducing ezrin translocation to apical membranes via Rho/ROCK pathway.

Authors:  Rattiyaporn Kanlaya; Visith Thongboonkerd
Journal:  Cell Mol Life Sci       Date:  2022-06-24       Impact factor: 9.261

4.  Lipopolysaccharide Domains Modulate Urovirulence.

Authors:  Lizath M Aguiniga; Ryan E Yaggie; Anthony J Schaeffer; David J Klumpp
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

5.  Management of Urinary Tract Infections in Direct to Consumer Telemedicine.

Authors:  Radhika Rastogi; Kathryn A Martinez; Niyati Gupta; Mark Rood; Michael B Rothberg
Journal:  J Gen Intern Med       Date:  2019-10-30       Impact factor: 5.128

6.  Intravesical instillations for the treatment of refractory recurrent urinary tract infections.

Authors:  Sonia Dutta; Felicia Lane
Journal:  Ther Adv Urol       Date:  2018-02-18

Review 7.  Contemporary management considerations of urinary tract infections for women with spina bifida.

Authors:  Ellen Fremion; Paola Bustillos; Rose Khavari
Journal:  Int Urogynecol J       Date:  2021-06-03       Impact factor: 2.894

8.  rUTI Resolution After FMT for Clostridioides difficile Infection: A Case Report.

Authors:  Andrea Aira; Elisa Rubio; Andrea Vergara Gómez; Csaba Fehér; Climent Casals-Pascual; Begoña González; Laura Morata; Verónica Rico; Alex Soriano
Journal:  Infect Dis Ther       Date:  2020-11-02

9.  Urinary prostaglandin E2 as a biomarker for recurrent UTI in postmenopausal women.

Authors:  Tahmineh Ebrahimzadeh; Amy Kuprasertkul; Michael L Neugent; Kevin C Lutz; Jorge L Fuentes; Jashkaran Gadhvi; Fatima Khan; Cong Zhang; Belle M Sharon; Kim Orth; Qiwei Li; Philippe E Zimmern; Nicole J De Nisco
Journal:  Life Sci Alliance       Date:  2021-05-06

10.  Outpatient prescribing and prophylactic antibiotic use for recurrent urinary tract infections in British Columbia, Canada.

Authors:  Ariana Saatchi; Ji Won Yoo; Fawziah Marra
Journal:  Can Urol Assoc J       Date:  2021-12       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.